We serve 2-Deoxy-L-ribose CAS:18546-37-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 2-Deoxy-L-ribose
CAS.NO:18546-37-7
Synonyms:
2-deoxy-L-erythro-pentose
L-erythro-2-deoxy-pentose
L-2-deoxyribose
(3R,4S)-3,4,5-Trihydroxypentanal
L-erythro-3,4,5-Trihydroxy-valeraldehyd
L-erythro-2-Desoxy-pentose
2-deoxy-L-ribose
L-erythro-Pentose,2-deoxy
L-threo-2-deoxy-pentose
L-ERYTHRO-PENTOFURANOSE
Molecular Formula:C5H10O4
Molecular Weight:134.13000
Physical and Chemical Properties:
Density: 1.516 g / cm3
Boiling point: 332.1ºC at 760 mmHg
Melting point: 69-72 ° C
Flash point: 154.6ºC
Refractive index: 1.5
Specification:
Appearance: White or yellowish crystalline powder
Purity:≥95%
Water:≤1.0%
Ethanol:≤5.0%
Formamide:≤3.0%
Heavy metal:≤0.002%
Sulphated ash:≤0.1%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Storage Condition:2-8ºC.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Telbivudine CAS:3424-98-4
Contact us for information like 2-Deoxy-L-ribose chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-ERYTHRO-PENTOFURANOSE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-threo-2-deoxy-pentose Use and application,L-erythro-2-deoxy-pentose technical grade,usp/ep/jp grade.
Related News: Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.Ethyl Cyclopropanecarboxylate manufacturer Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.4'-Hydroxy-3'-methylacetophenone supplier The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide vendor The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity.
